发布求助
搜索
全部 求助中 待确认 已完结
其它数据库
求助中 Dosimetric Predictors of Radiation Pneumonitis for Stage III NSCLC Treated With Neoadjuvant Immuno-chemotherapy and Definitive Chemoradiation: A Multi-institutional Analysis
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
已完结 Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2– metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
已完结 Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
已完结 Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer A Single-center Experience and Review of the Literature
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
Elsevier
已完结 How do carbon markets interact with energy-intensive sectors? Evidence from price connectedness
准备好了 准备好了
2026-09-02
10
下载文件
其它数据库
已完结 Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects International Cardio-Oncology Society Position Statement
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer The DEPEND Phase 2 Nonrandomized Clinical Trial
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
已完结 Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
Elsevier
已完结 Sodium alginate/tannic acid/PEDOT:PSS conductive hydrogels with in-situ calcium release-mediated gelation for accelerating diabetic wound healing
用户C9Afzt 用户C9Afzt
2026-09-02
10
下载文件
其它数据库
已完结 Magnetic Field-Induced Mass Transfer Acceleration and Spin Polarization for Highly Efficient Photocatalytic Urea Synthesis
用户Or98DP 用户Or98DP
2026-09-02
10
下载文件
其它数据库
已完结 Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: Research Summary.
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
已完结 Navigating Treatment Pathways in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Overcoming Primary and Acquired Resistance to Immunotherapy in Non–Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
已完结 How I Read a Clinical Trial Report? A Primer for Busy Clinicians.
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
下载文件
其它数据库
求助中 Regulation of immune checkpoint molecules in cancer immune evasion and therapy
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助
其它数据库
求助中 Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
用户Hk9Gh1 用户Hk9Gh1
2026-09-02
10
我要应助